Filing metadata

Accession number
0001127602-21-002963
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Jan 29, 2021
Reporting period
Jan 27, 2021
Description
Insider transaction

Explore SEC Filings Hub